Home › Funds › PNC Financial Services › CLGN
PNC Financial Services position in CLGN
COLLPLANT BIOTECHNOLOGIES LT · Health Care
Latest position (Q2 2024)3.60K sh
Reported value held$17.89K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 3.60K | $58.00K | New |
| Q1 2022 | 3.60K | $40.00K | Hold |
| Q2 2022 | 3.60K | $28.00K | Hold |
| Q3 2022 | 3.60K | $24.00K | Hold |
| Q4 2022 | 3.60K | $30.06K | Hold |
| Q1 2023 | 3.60K | $25.27K | Hold |
| Q2 2023 | 3.60K | $29.38K | Hold |
| Q3 2023 | 3.60K | $20.05K | Hold |
| Q4 2023 | 3.60K | $23.00K | Hold |
| Q1 2024 | 3.60K | $19.26K | Hold |
| Q2 2024 | 3.60K | $17.89K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLGN
- Renaissance Technologies 61.50K sh · $21.46K · Q2 2026
- Citadel Advisors 53.70K sh · $18.74K · Q2 2026
- UBS Group AG 1.03K sh · $361 · Q2 2026
- Morgan Stanley 1 sh · $1 · Q2 2026